Abstract
Renin-angiotensin system (RAS) blockade has been associated with improved outcomes in numerous disease states, including reduced mortality in congestive heart failure (CHF), hypertension, and diabetes ([1][1],[2][2]). RAS blockade remains central to the management of both cardiovascular disease and
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical journal of the American Society of Nephrology : CJASN
Paper Title
Journal
Date
